Aliev G - Search Results

1

Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion.

Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA. Aliev G, et al. Oxid Med Cell Longev. 2013;2013:962984. doi: 10.1155/2013/962984. Epub 2013 Apr 3. Oxid Med Cell Longev. 2013. PMID: 23691268 Free PMC article. Review.

2

Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.

Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA Jr, Benberin VV, Bachurin SO. Aliev G, et al. Curr Med Chem. 2014;21(19):2208-17. doi: 10.2174/0929867321666131227161303. Curr Med Chem. 2014. PMID: 24372221 Review.

3

Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, Morales L, Gasimov E, Bragin V. Aliev G, et al. Neurotox Res. 2009 Oct;16(3):293-305. doi: 10.1007/s12640-009-9066-5. Epub 2009 May 30. Neurotox Res. 2009. PMID: 19526276

4

Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases.

Aliev G, Li Y, Palacios HH, Obrenovich ME. Aliev G, et al. Recent Pat Cardiovasc Drug Discov. 2011 Sep;6(3):222-41. doi: 10.2174/157489011797376942. Recent Pat Cardiovasc Drug Discov. 2011. PMID: 21906026 Review.

5

Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Aliev G, et al. Neurotox Res. 2003;5(7):491-504. doi: 10.1007/BF03033159. Neurotox Res. 2003. PMID: 14715433 Review.

6

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.

Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, Perry G. Aliev G, et al. Vasc Health Risk Manag. 2008;4(3):721-30. doi: 10.2147/vhrm.s2608. Vasc Health Risk Manag. 2008. PMID: 18827923 Free PMC article.

7

Antioxidant therapy in Alzheimer's disease: theory and practice.

Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G. Aliev G, et al. Mini Rev Med Chem. 2008 Nov;8(13):1395-406. doi: 10.2174/138955708786369582. Mini Rev Med Chem. 2008. PMID: 18991755 Free PMC article. Review.

8

Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.

Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L. Aliev G, et al. Int J Biochem Cell Biol. 2009 Oct;41(10):1989-2004. doi: 10.1016/j.biocel.2009.03.015. Epub 2009 Apr 5. Int J Biochem Cell Biol. 2009. PMID: 19703659 Review.

9

Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease.

Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, Gąsiorowski K, Bragin V, Aliev G. Palacios HH, et al. Among authors: aliev g. CNS Neurol Disord Drug Targets. 2011 Mar;10(2):149-62. doi: 10.2174/187152711794480474. CNS Neurol Disord Drug Targets. 2011. PMID: 21222631 Review.

10

Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism.

Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG. Kosenko EA, et al. Among authors: aliev g. CNS Neurol Disord Drug Targets. 2014 Feb;13(1):112-9. doi: 10.2174/18715273113126660130. CNS Neurol Disord Drug Targets. 2014. PMID: 24040810 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters